Evidence map›Paper›PMID 35406648›Full record

ArticleCells2022

In Vitro Erythropoiesis at Different pO

Greta Simionato, Antonia Rabe, Joan Sebastián Gallego-Murillo, Carmen van der Zwaan, Arie Johan Hoogendijk, Maartje van den Biggelaar, Giampaolo Minetti, Anna Bogdanova, Heimo Mairbäurl, Christian Wagner and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Greta SimionatoDepartment of Experimental Physics, University Campus, Building E2.6, Saarland University, 66123 Saarbrücken, Germany.ORCID 0000-0001-5452-2275
Antonia RabeDepartment of Experimental Physics, University Campus, Building E2.6, Saarland University, 66123 Saarbrücken, Germany.
Joan Sebastián Gallego-MurilloSanquin Research, Landsteiner Laboratory, Department of Hematopoiesis, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Carmen van der ZwaanSanquin Research, Landsteiner Laboratory, Department of Molecular Hematology, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Arie Johan HoogendijkSanquin Research, Landsteiner Laboratory, Department of Molecular Hematology, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Maartje van den BiggelaarSanquin Research, Landsteiner Laboratory, Department of Molecular Hematology, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Giampaolo MinettiDepartment of Biology and Biotechnology "L. Spallanzani", Laboratories of Biochemistry, University of Pavia, I-27100 Pavia, Italy.ORCID 0000-0003-3063-4613
Anna BogdanovaRed Blood Cell Research Group, Institute of Veterinary Physiology, University of Zurich, CH-8057 Zurich, Switzerland.ORCID 0000-0003-0502-5381
Heimo MairbäurlUniversity Hospital Heidelberg, Medical Clinic VII, Sports Medicine, 69120 Heidelberg, Germany.
Christian WagnerDepartment of Experimental Physics, University Campus, Building E2.6, Saarland University, 66123 Saarbrücken, Germany.ORCID 0000-0001-7788-4594
Lars KaestnerDepartment of Experimental Physics, University Campus, Building E2.6, Saarland University, 66123 Saarbrücken, Germany.ORCID 0000-0001-6796-9535
Emile van den AkkerSanquin Research, Landsteiner Laboratory, Department of Hematopoiesis, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands.
Sanquin · NLSaarland University · DEHeidelberg University · DEUniversity of Luxembourg · LUUniversity of Pavia · ITUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia is associated with increased erythropoietin (EPO) release to drive erythropoiesis. At high altitude, EPO levels first increase and then decrease, although erythropoiesis remains elevated at a stable level. The roles of hypoxia and related EPO adjustments are not fully understood, which has contributed to the formulation of the theory of neocytolysis. We aimed to evaluate the role of oxygen exclusively on erythropoiesis, comparing in vitro erythroid differentiation performed at atmospheric oxygen, a lower oxygen concentration (three percent oxygen) and with cultures of erythroid precursors isolated from peripheral blood after a 19-day sojourn at high altitude (3450 m). Results highlight an accelerated erythroid maturation at low oxygen and more concave morphology of reticulocytes. No differences in deformability were observed in the formed reticulocytes in the tested conditions. Moreover, hematopoietic stem and progenitor cells isolated from blood affected by hypoxia at high altitude did not result in different erythroid development, suggesting no retention of a high-altitude signature but rather an immediate adaptation to oxygen concentration. This adaptation was observed during in vitro erythropoiesis at three percent oxygen by a significantly increased glycolytic metabolic profile. These hypoxia-induced effects on in vitro erythropoiesis fail to provide an intrinsic explanation of the concept of neocytolysis.

Indexed as

ErythropoiesisErythropoietinAcclimatizationHumansHypoxiaOxygenErythropoietinOxygenhigh altitudehypoxiain vitro erythropoiesisneocytolysispO2

Identifiers

PMID35406648
PMCPMC8997720
OpenAlexW4223521422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.